The alliance will pair BMS' library with Evotec's EVO panOmics ... an artificial intelligence software used to analyse the resulting data. "Molecular glues are one of the most exciting new ...
The deal – which could be worth up to $2.2 billion if PRX005 reaches the market – comes nearly a decade after BMS all-but exited the category after abandoning amyloid-targeting drug avagacestat.
Novartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs ...